VR

Vasudevan Reshiya

Director DIN 08682330
DIN 08682330 First appointment Jan 2020
Unlock full profile Investments Β· shareholding Β· contact details
Past companies 2 historical roles
Total affiliations 2 Since Jan 2020
Shareholding value β€’β€’β€’β€’ Premium profile

About Vasudevan Reshiya

Data last updated:

Vasudevan Reshiya was a Director at Chislon Pharmachem Private Limited (from 2021) and Director at Japheth Engineering Private Limited (from 2020).

DIN 08682330
First Appointment 28 Jan 2020
Oldest Company Age 6 yrs

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Chislon Pharmachem Private Limited U24304TN2021PTC141802
Director04 Mar 20212021Strike Off
Japheth Engineering Private Limited U74999TN2020PTC134071
Director28 Jan 20202020Strike Off

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Chislon Pharmachem Private Limited
Japheth Engineering Private Limited
Premium access

Shareholding and investment profile for Vasudevan Reshiya

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Vasudevan Reshiya

Vasudevan Reshiya was first appointed on 28 Jan 2020 as Director at Japheth Engineering Private Limited. The most recent appointment on record is 04 Mar 2021 at Chislon Pharmachem Private Limited.

Vasudevan Reshiya held 2 earlier board appointments: Chislon Pharmachem Private Limited (Director, from 04 Mar 2021); Japheth Engineering Private Limited (Director, from 28 Jan 2020).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available